At the highest dose tested, Vaxcyte’s shot elicited a stronger immune response against 18 of the 20 strains compared with ...

Sanofi Pasteur manufactures the DTP antigens used in the vaccine while Merck/MSD provides the Hib and HBV antigens. FDA approval comes almost three years after Vaxelis was registered in the EU ...

Other partners are Merck & Co (known as MSD outside the US and Canada), Softbox, AT&T, and Volans-i. Merck & Co and others test vaccine delivery drone | pharmaphorum Skip to main content ...

Chris Shibutani has given his Buy rating due to a combination of factors surrounding Merck & Company’s position in the Chinese market, particularly with its Gardasil HPV vaccine. Despite ...

The Cambridge, Massachusetts-based biotech has already reported encouraging mid-stage data for its personalized cancer vaccine, named mRNA-4157, in combination with Merck's (NYSE:MRK) anti-PD1 ...

In the same breath, Herbosa reiterated the government’s intention to launch the Bakuna Eskwela or school-based vaccination programs, including the introduction of the HPV vaccine for girls 14 ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Why are we seeing a summer uptick of COVID-19 cases? Expert weighs in Updated COVID-19 vaccines will likely be available in August or September and are being produced by Pfizer, Novavax ...

Many vaccines contain trace amounts of neomycin to prevent bacterial contamination during the manufacturing process. As a topical medicament, neomycin elicits a high sensitization rate.

(Bloomberg) -- More than $6.4 billion in health-care deals were announced on Monday as the annual JPMorgan Healthcare Conference kicked off in San Francisco. The deals include Merck & Co.’s $680 ...

Merck (MRK) closed the most recent trading day at $117.84, moving -0.63% from the previous trading ... sector's gain of 5.85% and the S&P 500's gain of 6.22%. The upcoming earnings release of ...